Dr. Reddy's Laboratories Statistics Share Statistics Dr. Reddy's Laboratories has 832.37M
shares outstanding. The number of shares has increased by -0.09%
in one year.
Shares Outstanding 832.37M Shares Change (YoY) -0.09% Shares Change (QoQ) -0.12% Owned by Institutions (%) 13.15% Shares Floating 832.35M Failed to Deliver (FTD) Shares 499 FTD / Avg. Volume 0.03%
Short Selling Information The latest short interest is 12.19M, so 1.46% of the outstanding
shares have been sold short.
Short Interest 12.19M Short % of Shares Out 1.46% Short % of Float 2.85% Short Ratio (days to cover) 8.98
Valuation Ratios The PE ratio is 16.63 and the forward
PE ratio is 0.22.
Dr. Reddy's Laboratories's PEG ratio is
10.58.
PE Ratio 16.63 Forward PE 0.22 PS Ratio 2.89 Forward PS 0 PB Ratio 2.82 P/FCF Ratio 78.16 PEG Ratio 10.58
Financial Ratio History Enterprise Valuation Dr. Reddy's Laboratories has an Enterprise Value (EV) of 972.37B.
EV / Sales 2.99 EV / EBITDA 10.06 EV / EBIT 20.94 EV / FCF 80.83
Financial Position The company has a current ratio of 1.92,
with a Debt / Equity ratio of 0.14.
Current Ratio 1.92 Quick Ratio 1.37 Debt / Equity 0.14 Debt / EBITDA 0.48 Debt / FCF 3.89 Interest Coverage 25.4
Financial Efficiency Return on Equity is 16.96% and Return on Invested Capital is 13.34%.
Return on Equity 16.96% Return on Assets 11.47% Return on Invested Capital 13.34% Revenue Per Employee $12.04M Profits Per Employee $2.09M Employee Count 27,048 Asset Turnover 0.66 Inventory Turnover 1.9
Taxes Income Tax 19.54B Effective Tax Rate 25.45%
Stock Price Statistics The stock price has increased by -16.05% in the
last 52 weeks. The beta is 0.31, so Dr. Reddy's Laboratories's
price volatility has been higher than the market average.
Beta 0.31 52-Week Price Change -16.05% 50-Day Moving Average 14.84 200-Day Moving Average 14.29 Relative Strength Index (RSI) 38.69 Average Volume (20 Days) 1,573,904
Income Statement In the last 12 months, Dr. Reddy's Laboratories had revenue of 325.54B
and earned 56.54B
in profits. Earnings per share was 67.85.
Revenue 325.54B Gross Profit 190.43B Operating Income 71.84B Net Income 56.54B EBITDA 96.67B EBIT 79.61B Earnings Per Share (EPS) 67.85
Full Income Statement Balance Sheet The company has 14.65B in cash and 46.77B in
debt, giving a net cash position of -32.11B.
Cash & Cash Equivalents 14.65B Total Debt 46.77B Net Cash -32.11B Retained Earnings 315.79B Total Assets 519.54B Working Capital 127.31B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 46.43B
and capital expenditures -34.4B, giving a free cash flow of 12.03B.
Operating Cash Flow 46.43B Capital Expenditures -34.4B Free Cash Flow 12.03B FCF Per Share 14.44
Full Cash Flow Statement Margins Gross margin is 58.5%, with operating and profit margins of 22.07% and 17.37%.
Gross Margin 58.5% Operating Margin 22.07% Pretax Margin 23.59% Profit Margin 17.37% EBITDA Margin 29.7% EBIT Margin 22.07% FCF Margin 3.7%
Dividends & Yields RDY pays an annual dividend of $0.19,
which amounts to a dividend yield of 0.62%.
Dividend Per Share $0.19 Dividend Yield 0.62% Dividend Growth (YoY) -5.01% Payout Ratio 24.26% Earnings Yield 6.01% FCF Yield 1.28%
Dividend Details Analyst Forecast The average price target for RDY is $16.95,
which is 22.7% higher than the current price. The consensus rating is "Strong Buy".
Price Target $16.95 Price Target Difference 22.7% Analyst Consensus Strong Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $1696.25 Lynch Upside 12182.77% Graham Number 781.54 Graham Upside 5559.23%
Stock Splits The last stock split was on Nov 5, 2024. It was a
forward
split with a ratio of 5:1.
Last Split Date Nov 5, 2024 Split Type forward Split Ratio 5:1
Scores Altman Z-Score 2.38 Piotroski F-Score 5
